Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-060883
Filing Date
2013-11-13
Accepted
2013-11-13 13:47:44
Documents
10
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v359979_10q.htm 10-Q 905536
2 EXHIBIT 31 v359979_ex31.htm EX-31 11112
3 EXHIBIT 32 v359979_ex32.htm EX-32 7865
4 GRAPHIC ft0002img-1.jpg GRAPHIC 46389
  Complete submission text file 0001144204-13-060883.txt   3885787

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT iccc-20130930.xml EX-101.INS 457075
6 XBRL TAXONOMY EXTENSION SCHEMA iccc-20130930.xsd EX-101.SCH 35702
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE iccc-20130930_cal.xml EX-101.CAL 30779
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE iccc-20130930_def.xml EX-101.DEF 151320
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE iccc-20130930_lab.xml EX-101.LAB 211743
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iccc-20130930_pre.xml EX-101.PRE 191310
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 131213848
SIC: 2835 In Vitro & In Vivo Diagnostic Substances